The investigation is looking into concerns whether Orthofix was involved with securities fraud or orther unlawful business practices.
The news comes less than a month after Orthofix announced leadership changes including an interim CEO, interim CFO and interim chief legal officer. The leadership shuffle was in response to an investigation that unveiled “repeated inappropriate and offensive conduct.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.